Blood test markers for diagnosing ulcerative colitis
Part of Digestive system, Immune system & allergy clinical trials.
This study looks at two proteins in the blood, oncostatin M and galectin-3, to see if they can help diagnose ulcerative colitis and tell if the disease is active. It may lead to a simpler way to check disease activity without invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with ulcerative colitis based on a biopsy and other tests
- You have not started treatment for ulcerative colitis yet
- You do not have other conditions that cause inflammation, like rheumatoid arthritis or asthma
- You have no history of cancer or other autoimmune diseases
- You do not have Crohn's disease or microscopic colitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This trial is testing a simple urine test that may show how active your ulcerative colitis is, using a substance called PGE-MUM. It could help doctors check your disease without needing a scope or other invasive tests.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study looks at how your blood tests (inflammation levels) change after you start or adjust your treatment for ulcerative colitis or Crohn's disease. It also checks how your gut heals by looking at tissue samples from a follow-up colonoscopy.
Hear when a new Ulcerative Colitis Disease Patients and Normal Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.